dr. H.M. (Hanneke) van Santen
dr. H.M. (Hanneke) van Santen
- Endocrinology patient care
Research Programs
Biography
Biography
Dr. H.M. van Santen is clinical researcher, pediatric endocrinologist, and committed to improve the endocrine outcome of children with (oncologic) disease.
"I have the vision that all children should have an optimal hormonal state enabling them to have an optimal daily quality of life and to develop and grow (comparable to their peers) into adulthood. For children with underlying disease, this requires cross-field thinking and collaboration with partners outside of one’s own domain. My mission is to improve outcome of children with any kind of disease by preventing or restoring their endocrine dysfunction. Within this mission, I focus on the key-player of the endocrine system; “the hypothalamus".
Dr. Van Santen moved her career in 2013 to Utrecht to coordinate the endocrine care for children with cancer in the Princess Máxima Center. She has co-authored > 150 papers on the endocrine effects of childhood cancer treatment, pediatric thyroid cancer , craniopharyngioma and hypothalamic dysfunction.
She is an active associate professor in the research program of Child Health, WKZ, UMCU and associate-PI in the Princess Máxima Centre for Pediatric Oncology. In the UMCU Utrecht, she is coordinator of the European Reference Centers for "Rare Hypothalamic Disease", "Pituitary tumors" and "Thyroid Tumors" and , within the Maxima, chair of the M4C Craniopharyngioma. Her research program focusses on hypothalamic dysfunction and hypothalamic obesity, craniopharyngioma, pediatric thyroid cancer and the endocrine effects of childhood cancer treatment. She is an internationally acknowledged expert on hypothalamic dysfunction and pediatric thyroid cancer with regular invited lectures both national and international.
She is the chair of the Dutch Pediatric Endocrinologists (NvK, sectie kinderendocrinologie), of the SIOPe craniopharyngioma working group, and of the European Guideline for Thyroid cancer in children. Together with the Late Effects of Childhood Cancer International Guideline Harmonization Groups (IGHG) she co-chairs the recommendations for thyroid and hypothalamic-pituitary disorders, and is member of the working groups for gonadal toxicity and preservation of fertility and metabolic syndrome.
Side Activities
2020 - now member of the WKZ Onderzoeksfonds Scientific Committee
2020 member of the Internal Grant committee Princess Maxima Center
2020 Chair SIOPe craniopharyngioma board
2020 Member of the Advisory board of the Academic Japanese Consortium for Juvenile Thyroid Cancer (JCJTC, president Dr Ohtsuru)
2020 co-PI Prinses Maxima Center for Pediatric Oncology Utrecht
2019 BKO qualification UMCU
2019 Chair of the European Task Force for Recommendations of Treatment of Thyroid nodules and Carcinoma in Childhood
2016 – now Deputy educator ( plaatsvervangend opleider) of the clinical fellow pediatric endocrinology in the Wilhelmina Children’s Hospital, UMCU
2018 - now member of working group supportive care Princess Maxima Center
2017 - now member of fertility working group Princess Maxima Center
2016 - now Co-chair of the IGHG for surveillance of hypothalamic-pituitary disorders in Childhood Cancer Survivors
2016 - now Participant/ member of the working group of the IGHG working group for preservation of fertility in male childhood cancer survivors (in progress)
2016 – now Participant / working group lead of the IGHG working group for preservation of fertility in female childhood cancer survivors (in progress)
2016 - now Participant/ member of the working group of the IGHG recommendation for surveillance of the metabolic syndrome in childhood cancer survivors (in progress)
2016 - now Co-chair of the Dutch Guideline for Treatment of Thyroid nodules and cancer in children (in progress)
2016 - now Participant of the SIOP supportive care group
2016 - now Participant of the SIOP low grade glioma working group
2016 - now Participant of the national consortium for Late effects of treatment for childhood thyroid carcinoma ( PI T Links, UMCG)
2016 - now Participant of the consortium of the Dexadagen-2 study
2015 - now Participant of the Dutch Growth Hormone Advisory board (SEK)
2015 - now Consultative function for the “Cyberpoli” for thyroid diseases and craniopharyngioma(www.cyberpoli.nl)
2015 – now Participant of the SKION LATER Recommendations for screening Childhood Cancer Survivors https://www.skion.nl/workspace/uploads/vertaling-richtlijn-LATER-versie-final-okt-2014_2.pdf
Fellowship and Awards
2020 ZonMW Stimuleringssubsidie "Implementatie van nieuw behandelalgoritme voor hypothalame obesitas bij kinderen met een supra-sellaire tumor"
2019 KIKA project: THYRO-Dynamics Study (Prospective study on thyroid function during treatment with chemotherapy in 600 children)
2019 Princess Maxima Grant; research grant for 4-year PhD student: “Building an organoid model for craniopharyngioma”
2009-2011 Fellowship kinderendocrinologie in het Emma Kinderziekenhuis AMC
Research Output (169)
Tamer Gizem, Arets Hubertus Gerardus Maria, van der Ent Cornelis Kors, van Santen Hanneke Margo, van der Kamp Hetty Jacoba 25 Jan 2024, In: Pediatric Pulmonology. 59 , p. 991-996
van Kalsbeek Rebecca J, Hudson Melissa M, Mulder Renée L, Ehrhardt Matthew, Green Daniel M, Mulrooney Daniel A, Hakkert Jessica, den Hartogh Jaap, Nijenhuis Anouk, van Santen Hanneke M, Schouten-van Meeteren Antoinette Y N, van Tinteren Harm, Verbruggen Lisanne C, Conklin Heather M, Jacola Lisa M, Webster Rachel Tillery, Partanen Marita, Kollen Wouter J W, Grootenhuis Martha A, Pieters Rob, Kremer Leontien C M, 14 Nov 2023, In: Nature Medicine. 30 , p. 603
Pluimakers V G, van Atteveld J E, de Winter D T C, Bolier M, Fiocco M, Nievelstein R A J, Janssens G O R, Bresters D, van der Heiden-van der Loo M, de Vries A C H, Louwerens M, van der Pal H J, Pluijm S M F, Ronckers C M, Versluijs A B, Kremer L C M, Loonen J J, van Dulmen-den Broeder E, Tissing W J E, van Santen H M, van den Heuvel-Eibrink M M, Neggers S J C M M 14 Oct 2023, In: European Journal of Endocrinology. 189 , p. 495-507 13 p.
de Vos-Kerkhof Evelien, Buis Dennis R, Lequin Maarten H, Bennebroek Carlien A, Aronica Eleonora, Hulleman Esther, Zwaveling-Soonawala Nitash, van Santen Hanneke M, Schouten-van Meeteren Antoinette Y N 11 Oct 2023, In: Frontiers in Endocrinology. 14
Samim Atia, Spijkers Suzanne, Moeskops Pim, Littooij Annemieke S, de Jong Pim A, Veldhuis Wouter B, de Vos Bob D, van Santen Hanneke M, Nievelstein Rutger A J 29 Aug 2023, In: Pediatric radiology. 53 , p. 2492-2501 10 p.
van Roessel I M A A, de Graaf J P, Biermasz N R, Charmandari E, van Santen H M 1 Aug 2023, In: Endocrine connections. 12
van Hulst Annelienke M., van den Akker Erica L.T., Verwaaijen Emma J., Fiocco Marta, Rensen Niki, van Litsenburg Raphaële R.L., Pluijm Saskia M.F., Zwaan C. Michel, van Santen Hanneke M., Pieters Rob, Evers Andrea W.M., Grootenhuis Martha A., van den Heuvel-Eibrink Marry M. Jul 2023, In: European Journal of Cancer. 187 , p. 124-133 10 p.
Van Schaik J, Schouten-van Meeteren A Y N, Vos-Kerkhof E, Janssens G O, Porro G L, Fiocco M, Bakker B, Tissing W J E, Hoving E W, van Santen H M 29 Jun 2023, In: Neuro-oncology. 25 , p. 2250-2261 12 p.
van Schaik Jiska, van Roessel Ichelle M A A, Bos Iris D, Claashen-van der Grinten Hedi L, Clement Sarah C, van Iersel Laura, Bakker Boudewijn, Meijer Lisethe, Kremer Leontien, Schouten-van Meeteren A Y Netteke, van Santen Hanneke M 20 Jun 2023, In: Journal of Neuroendocrinology. 35
van Kalsbeek Rebecca J, Hudson Melissa M, Mulder Renée L, Ehrhardt Matthew, Green Daniel M, Mulrooney Daniel A, Hakkert Jessica, den Hartogh Jaap, Nijenhuis Anouk, van Santen Hanneke M, Schouten-van Meeteren Antoinette Y N, van Tinteren Harm, Verbruggen Lisanne C, Conklin Heather M, Jacola Lisa M, Webster Rachel Tillery, Partanen Marita, Kollen Wouter J W, Grootenhuis Martha A, Pieters Rob, Kremer Leontien C M, 15 Jun 2023, In: Nature Medicine. 29 , p. 1340-1348 9 p.